| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Charles River Laboratories International, Inc. (CRL) has 18 insiders with recent SEC Form 4 filings, including 0 buys and 34 sells. CRL is classified in the Life Sciences Tools & Services industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 210.7K | $34.31M | - | |
| COO | 65.9K | $10.74M | - | |
| VP | 29.2K | $4.75M | - | |
| VP | 27.4K | $4.46M | - | |
| CFO | 17.3K | $2.82M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 3, 2021 | Knell Michael Gunnar67 | Csvp&Chief Accounting Officer | Sale+OE | 800 | $329.76 | $263,808.88 | -15.9% | +33.8% | -26.7% | |
| Jun 1, 2021 | Foster James C77 | Chairman, President And CEO | Sale+OE | 9,577 | $332.23 | $3,181,749.31 | -0.4% | +33.6% | -31.0% | |
| May 11, 2021 | Massaro George66 | Director | Sell | 371 | $320.06 | $118,742.73 | -1.3% | +27.7% | -30.6% | |
| May 7, 2021 | Foster James C77 | Chairman, President And CEO | Sell | 7,500 | $343.17 | $2,573,770.43 | -0.7% | +19.7% | -29.4% | |
| May 6, 2021 | Massaro George66 | Director | Sell | 3,370 | $336.96 | $1,135,560.77 | -12.0% | +23.6% | -28.2% | |
| May 4, 2021 | Smith David Ross63 | Corporate Executive VP &CFO | Sale+OE | 3,305 | $340.01 | $1,123,718.18 | -18.2% | +19.7% | -24.0% | |
| Apr 22, 2021 | Smith David Ross63 | Corporate Executive VP &CFO | Sale+OE | 3,845 | $330.00 | $1,268,850.00 | -20.6% | +17.7% | -16.7% | |
| Apr 15, 2021 | Smith David Ross63 | Corporate Executive VP &CFO | Sell | 2,000 | $320.00 | $640,000.00 | -11.9% | +19.3% | -11.2% | |
| Apr 6, 2021 | Girshick Birgit65 | Corporate Executive VP | Sale+OE | 19,310 | $302.37 | $5,838,806.25 | -14.2% | +24.9% | -5.4% | |
| Mar 1, 2021 | Smith David Ross63 | Corporate Executive VP &CFO | Sale+OE | 4,366 | $290.12 | $1,266,646.89 | -20.6% | - | - |